0 items USD 0.00Search
Your search for "qyresearch united states drugs melanoma treatment industry 2016 market research report" gave back 83406 results.
Summary Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T...
Catalog:
HYR
August 2021
Price: USD 1,800.00
Worldwide markets are poised to achieve continuing growth as the artificial intelligence software increases diagnostic excellence, saving lives and...
Catalog:
WinterGreen Research
October 2017
Price: USD 4,200.00
Summary The global Metastatic Melanoma Drug market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define,...
Catalog:
HYR
February 2022
Price: USD 1,940.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Global Checkpoint Inhibitors for Treating Cancer market will register a 28.0% CAGR in terms of revenue, reach US$ 20600 million by 2023, from US$...
Catalog:
MRRPB2
July 2018
Price: USD 4,960.00
Uvea is found in the back of the sclera and the cornea and has three parts: the iris, the ciliary body and the choroid. Uveal melanoma, including the...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Mucosal Melanoma Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global Mucosal Melanoma Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of %...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Melanoma Drugs market size was valued at US$ 2107.5 million in 2023. With growing demand in downstream market, the Melanoma Drugs is...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Melanoma drugs are medications used to treat melanoma, a type of skin cancer. They include targeted therapies, immunotherapies, and chemotherapy...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Melanoma drugs are medications used to treat melanoma, a type of skin cancer. They include targeted therapies, immunotherapies, and chemotherapy...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
